TSE:CLS

Celestica Inc (CLS.TO)

427.53
+43.28 (11.26%)
as of Sep 3, 2026, 8:00:01 pm Market Open.
213 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 37 opinions in the last 12 months.

Celestica Inc. (CLS) has received mixed reviews from various experts regarding its performance and prospects. Many acknowledge the company's strong alignment with the burgeoning AI infrastructure and data center demand, which has contributed to significant revenue growth over the past year. However, some experts express concerns over its valuation, citing its high price-to-earnings (PE) ratio and potential volatility as factors for caution. While there is enthusiasm about the company's execution and position within the AI buildout, several analysts suggest that the stock might be reaching a peak, indicating a possible need to trim positions or wait for a better entry point. Overall, the sentiment displays a range of opinions on holding or taking profits, emphasizing the stock's growth potential alongside its heightened risks related to market fluctuations and overvaluation pressures.

consensus icon
Consensus
Hold
valuation icon
Valuation
Overvalued
review icon
Similar
TSM
DON'T BUY
A very good company and have executed well in a difficult environment. Expects a lot more competition to come in from Asia. Could also be a laggard in any tech upswing. Too expensive.
DON'T BUY
Margins are being squeezed. Treat as the trading stock.
DON'T BUY
Ahead of itself. Their margins could continue to be squeezed. Look for a 20% pullback before buying.
BUY
Good balance sheet. Good risk reward.
DON'T BUY
Pretty expensive. Doesn’t see underlying demand for their services growing as fast as the stock price.
DON'T BUY
A good business, but margins are getting thinner with the new contracts. Will take a while. Fully priced.
DON'T BUY
With the lack lustre demand, they will continue to struggle.
DON'T BUY
More incline to short this stock. Has not performed well during the recent rally. Thin margins.
DON'T BUY
Valuation looks too high. End demand is weak. Margins are very thin.
BUY
Love the company and its financial discipline. The issue is the valuation. Would buy at $17/18.
BUY
A lot of cash on the balance sheet.
BUY
Has had a nice run. Have to get their European market to turn around. Also has to demonstrate that they mon't lose market share.
BUY
Not expensive. Free cash flow. Volatile.
BUY ON WEAKNESS
Can be a trader between $14.50 and $25. No fundamerntals or earnings.
DON'T BUY
Very volatile.
Showing 316 to 330 of 575 entries